NEW YORK, April 24 -  Microbead maker Luminex on Tuesday reported revenues of $3.9 million in the first quarter of 2001, up from $1.4 million in the year-ago quarter and in-line with its recently reduced forecast.

Last week the company slashed its revenue expectations for the first quarter of 2001, citing its partners’ delays in commercializing bioassay kits based on its technology. The company had initially forecasted that its first-quarter revenues would total $4.2 million to $4.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.